Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis
EK Morgen, H-J Lenz, DJ Jonker, D Tu, G Milano, F Graziano, J Zalcberg, CS Karapetis, A Dobrovic, CJ O'Callaghan, G Liu
The Pharmacogenomics Journal | NATURE PUBLISHING GROUP | Published : 2017
H-JL: advisory board member for Merck KG, Bristol Myers Squibb clinical trial support, Merck Serono and Bristol Myers Squibb. GM: Merck Serono honorarium. JZ: travel and research support to Merck Serono. CSK: advisory board member for Amgen and Merck Serono. AD: advisory board member for Amgen. GL: advisory board member for Roche, Astra Zeneca, Novartis, Pfizer and Merck Serono. The remaining authors declare no conflict of interest.